NextFerm Technologies Ltd.
TTASE:NXFR.M2,779.00
ILA
+275.00
(+10.98%)
ISIN
IL0011719338
Return %
Stock
S&P 500
1Y
-72.24
14.20
3Y
-92.08
81.12
5Y
-99.77
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Boaz Noy
- Sector
- Consumer non-durables
- Industry
- Food: major diversified
- Address
- Yokneam Illit Israel
- IPO Date
- Jan 26, 2021
- Website
- nextferm.com
- Similar Companies
- Business
- NextFerm Technologies Ltd. is a food technology and biotechnology company that engages in the research, development, production, and commercialization of yeast-derived, non-genetically modified nutritional ingredients and alternative protein solutions. Founded in 2013 and headquartered in Yokneam Illit, Israel, the company utilizes proprietary yeast-breeding and industrial fermentation platforms to serve the global food, beverage, sports nutrition, and dietary supplement industries. NextFerm Technologies Ltd. provides a specialized product portfolio comprising: ProteVin, a vegan, non-GMO, yeast-fermented protein isolate featuring a neutral flavor profile, high digestibility, and a complete amino acid profile comparable to animal whey protein for applications in functional beverages, sports nutrition, dairy alternatives, and plant-based meat products; AstaFerm, a yeast-fermented, odorless, and flavorless astaxanthin antioxidant derived from Phaffia rhodozyma for use in dietary supplements, functional gummies, softgels, and powder premixes; and fermentation-derived yeast extracts and active biomass derivatives designed for clean-label nutritional enhancement and functional food formulations. The company markets its products to food and beverage manufacturers, nutraceutical enterprises, and supplement brand owners across North America, Europe, and the Asia-Pacific region. In recent operational developments, NextFerm Technologies Ltd. has advanced its global supply and scaling strategy through a commercial manufacturing agreement and partnership with Kothari Fermentation and Biochem Ltd. in India to produce yeast extracts and expand ProteVin production, complementing earlier contract manufacturing partnerships in Europe. The company has further broadened its commercial footprint by securing commercial orders across markets including the United States, France, Spain, and Singapore, achieving FSSC 22000 food safety manufacturing certifications, and undertaking operational restructuring initiatives to align production capacities with commercial demand.